Skip to main content
Premium Trial:

Request an Annual Quote

Shimadzu Establishes Taiwan Operations

NEW YORK (GenomeWeb News) – Shimadzu recently announced the creation of a wholly owned sales company in Taiwan to increase its presence there.

The new firm called Shimadzu Scientific Instruments, or SST, officially launches on April 8 and will sell Shimadzu instruments directly into the Taiwanese market. Shimadzu had previously offered its products in that market through local distributors.

The operations will be based in Taipei and will have 13 employees in its first fiscal year.

SST will have an application laboratory equipped with mass spectrometers, high-performance liquid chromatography systems, and other analytical and measurement instruments. Using its platforms, the company will develop and "propose on-target analytical methods" for customer needs.

The goal, Shimadzu said, is to increase sales in Taiwan to $13 million by 2017 from $4.5 million in 2012, it said.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.